Stem Cell Therapy in Spinal Cord Injury: In Vivo and Postmortem Tracking of Bone Marrow Mononuclear or Mesenchymal Stem Cells
- 939 Downloads
The aim of this study was to address the question of whether bone marrow-originated mononuclear cells (MNC) or mesenchymal stem cells (MSC) induce neural regeneration when implanted intraspinally.
Materials and Methods
The study design included 4 groups of mice: Group 1, non-traumatized control group; Groups 2, 3 and 4 spinal cord traumatized mice with 1 g force Tator clips, which received intralesionally either no cellular implants (Group 2), luciferase (Luc) (+) MNC (Group 3) or MSC (Group 4) obtained from CMV-Luc or beta-actin Luc donor transgenic mice. Following the surgery until decapitation, periodical radioluminescence imaging (RLI) and Basso Mouse Scale (BMS) evaluations was performed to monitor neural activity. Postmortem immunohistochemical techniques were used to analyze the fate of donor type implanted cells.
All mice of Groups 3 and 4 showed various degrees of improvement in the BMS scores, whereas there was no change in Groups 1 and 2. The functional improvement was significantly better in Group 4 compared to Group 3 (18 vs 8, p = 0.002). The immunohistochemical staining demonstrated GFP+Luc+ neuronal/glial cells that were also positive with one or more of these markers: nestin, myelin associated glycoprotein, microtubule associated protein or myelin oligodendrocyte specific protein, which is considered as indicator of donor type neuronal regeneration. Frequency of donor type neuronal cells; Luc + signals and median BMS scores were observed 48–64 % and 68–72 %; 44–80 %; 8 and 18 within Groups III and IV respectively.
MSCs were more effective than MNC in obtaining neuronal recovery. Substantial but incomplete functional improvement was associated with donor type in vivo imaging signals more frequently than the number of neuronal cells expressing donor markers in spinal cord sections in vitro. Our results are in favor of functional recovery arising from both donor MSC and MNCs, contributing to direct neuronal regeneration and additional indirect mechanisms.
KeywordsMesenchymal stem cell Regeneration Spinal cord Stem cell Trauma
This study was supported by grants from the Turkish Scientific Research Council TUBİTAK, Ankara University Research Resources (SBAG) and the Turkish Academy of Sciences.
Conflicts of Interest
The authors declare no potential conflicts of interest.
- 1.Duda, J., Karimi, M., Negrin, R. S. (2007). Methods for ımaging cells fates in hematopoiesis. In M. Beksac (Ed.), Bone marrow and stem cell transplantation (pp. 17–34).Google Scholar
- 3.Rivlin, A. S., & Tator, C. H. (1978). Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surgical Neurology, 10(1), 39–43.Google Scholar
- 7.Wislet-Gendebien, S., Bruyère, F., Hans, G., Leprince, P., Moonen, G., & Rogister, B. (2004). Nestinpositive mesenchymal stem cells favour the astroglial lineage in neuralprogenitors and stem cells by releasing active BMP4. BMC Neuroscience, 15, 5–33.Google Scholar
- 8.Lee, J., Kuroda, S., Shichinohe, H., Ikeda, J., Seki, T., Hida, K., et al. (2003). Migration and differentiation of nuclear fluorescence-labeled bone marrow stromal cells after transplantation into cerebral infarct and spinal cord injury in mice. Neuropathology, 23(3), 169–180.PubMedCrossRefGoogle Scholar
- 18.Deng, W., Obrocka, M., Fischer, I., & Prockop, D. J. (2001). In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. Biochemical and Biophysical Research Communications, 282(1), 148–152.PubMedCrossRefGoogle Scholar
- 36.Mujtaba, T., Han, S. S., Fischer, I., Sandgren, E. P., & Rao, M. S. (2002). Stable expression of the alkaline phosphatase marker gene by neural cells in culture and after transplantation into the CNS using cells derived from a transgenic rat. Experimental Neurology, 174(1), 48–57.PubMedCrossRefGoogle Scholar